Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan-Mar;44(1):40-48.
doi: 10.1016/j.htct.2020.08.017. Epub 2020 Nov 22.

Overview of lymphoma diagnosis in Brazilian public health system patients: Open data analysis for health care planning

Denise Pires Martins  1 , Nelson Francisco Correa-Netto  2 , Nina Melo  2 , Sandra Regina Loggetto  2 , Marcia Mello Costa de Liberal  2
Affiliations

Overview of lymphoma diagnosis in Brazilian public health system patients: Open data analysis for health care planning

Denise Pires Martins et al. Hematol Transfus Cell Ther. 2022 Jan-Mar.

Abstract

Introduction: Knowing the information regarding the panorama of lymphoma diagnosis in patients treated in the Brazilian Public Unified Health System from the last 10 years is a challenge for Strategic Health Planning.

Objective: To characterize the Brazilian population with lymphoma treated in the Brazilian Public Unified Health System between 2008 and 2017 regarding staging, sex, residence site and mortality.

Material and methods: A descriptive, retrospective, and longitudinal trial with secondary data from DataSUS (SIA/SUS and SIM/SUS) obtained from patients with ICD-10 C81-85.

Results: There were 70,850 lymphoma cases between 2008 and 2017, of which 55% were male, the median age was 51 years, and 27% had Hodgkin Lymphoma. Most patients (56%) were treated outside the residence city. São Paulo State accounted for 25% of patients. Treatment initiation took more than 60 days in 27% of cases. A total of 45,601 deaths were due to lymphoma (12% Hodgkin Lymphoma and 88% Non-Hodgkin Lymphoma), with a median age 63 years, and were mainly males (55%). Staging data were inadequate in 23% of patients, and analysis was performed only on the valid records. Advanced disease was diagnosed in 58% of patients (60% male; 57% female) and was more common in Non-Hodgkin Lymphoma (62%) versus Hodgkin Lymphoma (49%).

Discussion: Late diagnosis interferes with mortality rates. Health promotion and cancer prevention campaigns, especially targeting the male public, and training for early diagnosis and early treatment are needed.

Conclusion: Effective measures for early diagnosis and treatment are urgently needed for lymphoma control.

Keywords: Delayed diagnosis; Lymphoma; Mortality; Neoplasm staging; Neoplasms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proportions of patient diagnosis staging related to lymphoma and treated by the SUS from 2008 to 2017, according to sex and type of lymphoma.
See this image and copyright information in PMC

References

    1. Correa N. Trajetória da Incidência e Mortalidade das Neoplasias Hematológicas no Brasil. Observatório de Oncologia. 2019 Available in: https://observatoriodeoncologia.com.br/trajetoria-da-incidencia-e-mortal... [cited 19 November 2019]
    1. Cepas T. O Aumento das Mortes por Câncer no Brasil, 2005–2016. Observatório de Oncologia. 2018 Available in: https://observatoriodeoncologia.com.br/o-crescimento-das-mortes-por-canc... [cited 19 November 2019]
    1. Matarazo H. 2029: Ano em que o Câncer será a Primeira Causa de Morte no Brasil. Observatório de Oncologia. 2016 Available in: https://observatoriodeoncologia.com.br/2029-ano-em-que-o-cancer-sera-a-p... [cited 19 November 2019]
    1. Brasil . INCA; Rio de Janeiro: 2018. Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva – INCA. Estimativa 2018: Incidência de Câncer no Brasil. Available in: http://www1.inca.gov.br/estimativa/2018/estimativa-2018.pdf [cited 19 November 2019].
    1. American Cancer Society [homepage on internet]. Survival Rates and Factors That Affect Prognosis (Outlook) for Non-Hodgkin Lymphoma. Available in: https://www.cancer.org/cancer/non-hodgkin-lymphoma/detection-diagnosis-s... [cited 19 November 2019].